Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells-Reference-Cited by-同舟云学术

Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells

Published:2018-05 Issue:5 Volume:20 Page:728-739
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Jin Ping,Chen Wenjing,Ren Jiaqiang,Chen Steven,Wood Lauren,Zhao Yingdong,Remaley Alan,Pham Chauha,Lian Sheena,Liu Shutong,Liu Hui,Highfill Steven,Berzofsky Jay A.,Stroncek David F.

Funder

Intramural Research Program

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference15 articles.

1. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions;Selvaggi;Blood,1997

2. Anaphylaxis to infusion of autologous bone marrow: an apparent reaction to self, mediated by IgE antibody to bovine serum albumin;Macy;J Allergy Clin Immunol,1989

3. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells;Mackensen;Cancer Immunol Immunother,2000

4. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

5. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19;Kochenderfer;Blood,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOMAmer reagents and the SomaScan platform: Chemically modified aptamers and their applications in therapeutics, diagnostics, and proteomics;RNA Therapeutics;2022

2. Proteomic biomarker technology for cancer immunotherapy;Engineering Technologies and Clinical Translation;2022

3. Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy;Frontiers in Oncology;2021-12-16

4. 610 Technical challenges in monocyte-derived dendritic cell vaccine manufacturing; a QI project;Journal for ImmunoTherapy of Cancer;2020-11